Segui
Alessandro Blasimme
Alessandro Blasimme
ETH Zurich
Email verificata su inserm.fr
Titolo
Citata da
Citata da
Anno
Machine learning in medicine: addressing ethical challenges
E Vayena, A Blasimme, IG Cohen
PLoS medicine 15 (11), e1002689, 2018
2912018
Explainability for artificial intelligence in healthcare: a multidisciplinary perspective
J Amann, A Blasimme, E Vayena, D Frey, VI Madai
BMC Medical Informatics and Decision Making 20 (1), 1-9, 2020
1742020
Operational definition of active and healthy ageing (AHA): a conceptual framework
J Bousquet, D Kuh, M Bewick, T Standberg, J Farrell, R Pengelly, ME Joel, ...
The journal of nutrition, health & aging 19 (9), 955-960, 2015
962015
Biomedical big data: new models of control over access, use and governance
E Vayena, A Blasimme
Journal of bioethical inquiry 14 (4), 501-513, 2017
952017
Digital health: meeting the ethical and policy challenges
E Vayena, T Haeusermann, A Adjekum, A Blasimme
Swiss medical weekly 148, w14571, 2018
922018
Mapping the translational science policy ‘valley of death’
EM Meslin, A Blasimme, A Cambon-Thomsen
Clinical and translational medicine 2 (1), 1-8, 2013
872013
Health research with big data: Time for systemic oversight
E Vayena, A Blasimme
Journal of Law, Medicine & Ethics 46 (1), 119-129, 2018
752018
Cell reprogramming requires silencing of a core subset of polycomb targets
G Fragola, PL Germain, P Laise, A Cuomo, A Blasimme, F Gross, ...
PLoS genetics 9 (2), e1003292, 2013
662013
Elements of trust in digital health systems: scoping review
A Adjekum, A Blasimme, E Vayena
Journal of medical Internet research 20 (12), e11254, 2018
612018
Open sharing of genomic data: Who does it and why?
T Haeusermann, B Greshake, A Blasimme, D Irdam, M Richards, ...
PLoS One 12 (5), e0177158, 2017
612017
What's next for COVID-19 apps? Governance and oversight
A Blasimme, E Vayena
Science 370 (6518), 760-762, 2020
592020
Data sharing for precision medicine: policy lessons and future directions
A Blasimme, M Fadda, M Schneider, E Vayena
Health Affairs 37 (5), 702-709, 2018
582018
Operational definition of active and healthy aging (AHA): the European innovation partnership (EIP) on AHA reference site questionnaire: Montpellier October 20–21, 2014, Lisboná…
J Bousquet, J Malva, M Nogues, LR Ma˝as, B Vellas, J Farrell, M Bewick, ...
Journal of the American Medical Directors Association 16 (12), 1020-1026, 2015
552015
Becoming partners, retaining autonomy: ethical considerations on the development of precision medicine
A Blasimme, E Vayena
BMC Medical Ethics 17 (67), 2016
472016
Familial Alzheimer's disease sustained by presenilin 2 mutations: Systematic review of literature and genotype–phenotype correlation
M Canevelli, P Piscopo, G Talarico, N Vanacore, A Blasimme, A Crestini, ...
Neuroscience & Biobehavioral Reviews 42, 170-179, 2014
412014
Regulation of cell-based therapies in Europe: current challenges and emerging issues
A Blasimme, E Rial-Sebbag
Stem cells and development 22 (S1), 14-19, 2013
412013
Big data and dementia: charting the route ahead for research, ethics, and policy
M Ienca, E Vayena, A Blasimme
Frontiers in medicine 5, 13, 2018
392018
Improving the measurement of scientific success by reporting a self-citation index
JW Flatt, A Blasimme, E Vayena
Publications 5 (3), 20, 2017
372017
Democratizing health research through data cooperatives
A Blasimme, E Vayena, E Hafen
Philosophy & Technology 31 (3), 473-479, 2018
332018
" Tailored-to-You": Public Engagement and the Political Legitimation of Precision Medicine
A Blasimme, E Vayena
Perspectives in Biology and Medicine 59 (2), 172-188, 2016
292016
Il sistema al momento non pu˛ eseguire l'operazione. Riprova pi¨ tardi.
Articoli 1–20